Abstract |
Entire C-genotype small hepatitis B surface ( SHBs) sequences were isolated from 139 nucleos(t)ide analogues (NA)-naïve and 74 lamivudine (LMV)-treated chronic hepatitis B (CHB) patients. The conservation and variability of total 226 amino acids (AAs) within the sequences were determined individually, revealing significant higher mutant isolate rate and mutation frequency in LMV-treated cohort than those in the NA-naïve one (P=0.009 and 0.0001, respectively). Three absolutely conserved fragments (s16-s19, s176-s181 and s185-s188) and seven moderately conserved regions (a few AA sites acquiring increased variability after LMV-treatment) were identified. The significant mutation rate increase after LMV-treatment occurred primarily in major hydrophilic region (except 'a' determinant) and transmembrane domain 3/4, but not in other upstream functional regions of SHBs. With little influence on immune escape-associated mutation frequencies within 'a' determinant, LMV-monotherapy significantly induced classical LMVr-associated mirror changes sE164D/rtV173L, sI195M/rtM204V and sW196L/S/rtM204I, as well as non-classical ones sG44E/rtS53N, sT47K/A/rtH55R/Q and sW182stop/rtV191I outside 'a' determinant. Interestingly, another newly-identified truncation mutation sC69stop/rtS78T decreased from 7.91% (11/139) in NA-naïve cohort to 2.70% (2/74) in LMV-treated one. Altogether, the altered AA conservation and diversity in SHBs sequences after LMV-treatment in genotype-C HBV infection might shed new insights into how LMV- therapy affects the SHBs variant evolution and its antigenicity.
|
Authors | Hai Ding, Baoming Liu, Chengyu Zhao, Jingxian Yang, Chunhui Yan, Ling Yan, Hui Zhuang, Tong Li |
Journal | Antiviral research
(Antiviral Res)
Vol. 102
Pg. 29-34
(Feb 2014)
ISSN: 1872-9096 [Electronic] Netherlands |
PMID | 24316031
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2013 Elsevier B.V. All rights reserved. |
Chemical References |
- Antiviral Agents
- Codon, Nonsense
- Hepatitis B Surface Antigens
- Lamivudine
|
Topics |
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Amino Acid Substitution
- Antiviral Agents
(therapeutic use)
- Codon, Nonsense
- Female
- Genotype
- Hepatitis B Surface Antigens
(genetics)
- Hepatitis B virus
(classification, genetics, isolation & purification)
- Hepatitis B, Chronic
(drug therapy, virology)
- Humans
- Lamivudine
(therapeutic use)
- Male
- Middle Aged
- Mutation, Missense
- Young Adult
|